nodes	percent_of_prediction	percent_of_DWPC	metapath
Nandrolone phenpropionate—AR—Nuclear Receptors—NR4A2—schizophrenia	0.0379	0.0444	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—PAWR—schizophrenia	0.0342	0.0401	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—NOS1AP—schizophrenia	0.0331	0.0388	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptor transcription pathway—NR4A2—schizophrenia	0.0299	0.0351	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of Androgen receptor activity—SMARCA2—schizophrenia	0.0247	0.0289	CbGpPWpGaD
Nandrolone phenpropionate—Nandrolone decanoate—MAOA—schizophrenia	0.0232	0.162	CrCbGaD
Nandrolone phenpropionate—Ethynodiol—ESR1—schizophrenia	0.0226	0.158	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Tryptophan metabolism—TPH1—schizophrenia	0.0212	0.0249	CbGpPWpGaD
Nandrolone phenpropionate—Testosterone Propionate—COMT—schizophrenia	0.0211	0.147	CrCbGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—TLE1—schizophrenia	0.0211	0.0247	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP26B1—schizophrenia	0.0192	0.0225	CbGpPWpGaD
Nandrolone phenpropionate—Norgestimate—ESR1—schizophrenia	0.0192	0.134	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Oxidation by Cytochrome P450—CYP26B1—schizophrenia	0.019	0.0222	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—PAK6—schizophrenia	0.0171	0.02	CbGpPWpGaD
Nandrolone phenpropionate—Etonogestrel—ESR1—schizophrenia	0.0166	0.116	CrCbGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—TCF4—schizophrenia	0.0157	0.0184	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Phase 1 - Functionalization of compounds—CYP26B1—schizophrenia	0.0156	0.0183	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—FSH signaling pathway—BDNF—schizophrenia	0.0143	0.0167	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TLE1—schizophrenia	0.0138	0.0161	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TCF4—schizophrenia	0.0126	0.0148	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—HTR3A—schizophrenia	0.0122	0.0143	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—NDST3—schizophrenia	0.0119	0.014	CbGpPWpGaD
Nandrolone phenpropionate—Levonorgestrel—ESR1—schizophrenia	0.0118	0.0822	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Tryptophan metabolism—CYP1A2—schizophrenia	0.0116	0.0136	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2D6—schizophrenia	0.0104	0.0122	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Oxidation by Cytochrome P450—CYP2D6—schizophrenia	0.0102	0.012	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—FOS—schizophrenia	0.01	0.0118	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptors—ESR1—schizophrenia	0.00947	0.0111	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A2—schizophrenia	0.00939	0.011	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—HSPA8—schizophrenia	0.00936	0.011	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—TPH1—schizophrenia	0.00927	0.0109	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—CHRNA7—schizophrenia	0.00927	0.0109	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Oxidation by Cytochrome P450—CYP1A2—schizophrenia	0.00927	0.0109	CbGpPWpGaD
Nandrolone phenpropionate—AR—FOXA1 transcription factor network—ESR1—schizophrenia	0.00842	0.00987	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Phase 1 - Functionalization of compounds—CYP2D6—schizophrenia	0.00842	0.00987	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—CYP26B1—schizophrenia	0.00828	0.00971	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—CYP26B1—schizophrenia	0.00817	0.00958	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—GRIN1—schizophrenia	0.00772	0.00905	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A2—schizophrenia	0.00761	0.00893	CbGpPWpGaD
Nandrolone phenpropionate—AR—FOXA1 transcription factor network—FOS—schizophrenia	0.00759	0.0089	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptor transcription pathway—ESR1—schizophrenia	0.00748	0.00877	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—GCLM—schizophrenia	0.00738	0.00865	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—GAPDH—schizophrenia	0.00728	0.00853	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—TPH2—schizophrenia	0.00703	0.00824	CbGpPWpGaD
Nandrolone phenpropionate—Testosterone—MAOA—schizophrenia	0.0069	0.0482	CrCbGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—CHRNB2—schizophrenia	0.00666	0.0078	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of Androgen receptor activity—GSK3B—schizophrenia	0.00658	0.00772	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—IL10—schizophrenia	0.00658	0.00771	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—MEF2C—schizophrenia	0.0064	0.0075	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Phase 1 - Functionalization of compounds—MAOA—schizophrenia	0.00633	0.00743	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—YWHAZ—schizophrenia	0.00625	0.00733	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—CHRNA4—schizophrenia	0.00604	0.00709	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—HTR1A—schizophrenia	0.00582	0.00682	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—SNAP25—schizophrenia	0.00562	0.00659	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—SLC6A4—schizophrenia	0.00562	0.00659	CbGpPWpGaD
Nandrolone phenpropionate—Progesterone—ESR1—schizophrenia	0.00556	0.0388	CrCbGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—NTRK2—schizophrenia	0.00547	0.00641	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—NR4A2—schizophrenia	0.00517	0.00606	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—schizophrenia	0.00517	0.00606	CbGpPWpGaD
Nandrolone phenpropionate—AR—FOXA1 transcription factor network—EP300—schizophrenia	0.00503	0.00589	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—TH—schizophrenia	0.00501	0.00587	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—EP300—schizophrenia	0.00477	0.00559	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—FOS—schizophrenia	0.00466	0.00546	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—CYP2D6—schizophrenia	0.00447	0.00524	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—CYP2D6—schizophrenia	0.00441	0.00517	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—SLC27A5—schizophrenia	0.0044	0.00516	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—ACSL6—schizophrenia	0.0044	0.00516	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—GSK3B—schizophrenia	0.00435	0.0051	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—TSNAX—schizophrenia	0.00433	0.00508	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of Androgen receptor activity—EP300—schizophrenia	0.00433	0.00508	CbGpPWpGaD
Nandrolone phenpropionate—Progesterone—CYP1A2—schizophrenia	0.00428	0.0299	CrCbGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—MAOA—schizophrenia	0.00423	0.00496	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—BDNF—schizophrenia	0.00408	0.00478	CbGpPWpGaD
Nandrolone phenpropionate—Norethindrone—ABCB1—schizophrenia	0.00405	0.0283	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—CYP1A2—schizophrenia	0.00404	0.00474	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—AKT1—schizophrenia	0.00402	0.00471	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—CYP1A2—schizophrenia	0.00399	0.00468	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—IL10—schizophrenia	0.00389	0.00457	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—FSH signaling pathway—AKT1—schizophrenia	0.00386	0.00453	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—MEF2C—schizophrenia	0.00379	0.00444	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—YWHAZ—schizophrenia	0.00366	0.00429	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—LSM1—schizophrenia	0.00353	0.00414	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PIP4K2A—schizophrenia	0.00352	0.00412	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—BDNF—schizophrenia	0.00347	0.00407	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—HTR2A—schizophrenia	0.00345	0.00404	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—ABCB1—schizophrenia	0.00341	0.004	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—COMT—schizophrenia	0.00339	0.00397	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—GSTP1—schizophrenia	0.00337	0.00395	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—MAOA—schizophrenia	0.00336	0.00395	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—COMT—schizophrenia	0.00334	0.00392	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—GSTP1—schizophrenia	0.00333	0.0039	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—PLA2G4A—schizophrenia	0.00331	0.00388	CbGpPWpGaD
Nandrolone phenpropionate—Progesterone—CYP2D6—schizophrenia	0.00331	0.0231	CrCbGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—ESR1—schizophrenia	0.00314	0.00368	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—schizophrenia	0.00312	0.00365	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—GSTM1—schizophrenia	0.0031	0.00363	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—EP300—schizophrenia	0.00308	0.00362	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—GSTM1—schizophrenia	0.00306	0.00358	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PRODH—schizophrenia	0.0029	0.0034	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—EP300—schizophrenia	0.00286	0.00335	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—ESR1—schizophrenia	0.0027	0.00317	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PRKD1—schizophrenia	0.00266	0.00312	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—NOTCH4—schizophrenia	0.00265	0.0031	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—ESR1—schizophrenia	0.0026	0.00305	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—NR4A2—schizophrenia	0.00249	0.00292	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—MPC2—schizophrenia	0.00236	0.00277	CbGpPWpGaD
Nandrolone phenpropionate—Progesterone—ABCB1—schizophrenia	0.00236	0.0165	CrCbGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—AKT1—schizophrenia	0.00234	0.00274	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—SMG6—schizophrenia	0.00228	0.00267	CbGpPWpGaD
Nandrolone phenpropionate—Testosterone—ABCB1—schizophrenia	0.00223	0.0156	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—CLOCK—schizophrenia	0.0022	0.00258	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PLCH2—schizophrenia	0.0022	0.00258	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—NDST3—schizophrenia	0.00207	0.00242	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—IL1B—schizophrenia	0.00204	0.0024	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SLC27A5—schizophrenia	0.00196	0.0023	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ACSL6—schizophrenia	0.00196	0.0023	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3C2A—schizophrenia	0.00191	0.00224	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—EP300—schizophrenia	0.00187	0.0022	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—DAO—schizophrenia	0.00187	0.00219	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—schizophrenia	0.00186	0.00219	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—EP300—schizophrenia	0.00183	0.00214	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PNP—schizophrenia	0.00179	0.0021	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—AKT1—schizophrenia	0.00173	0.00203	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—NDUFV2—schizophrenia	0.00167	0.00195	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—EP300—schizophrenia	0.00161	0.00189	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PIP4K2A—schizophrenia	0.00157	0.00184	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—EP300—schizophrenia	0.00155	0.00182	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A2—schizophrenia	0.00155	0.00182	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—TNF—schizophrenia	0.00148	0.00174	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYP26B1—schizophrenia	0.00142	0.00166	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—TP53—schizophrenia	0.00134	0.00157	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—ESR1—schizophrenia	0.00129	0.00152	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—NOTCH4—schizophrenia	0.00127	0.00149	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—TPH1—schizophrenia	0.00126	0.00148	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GCLM—schizophrenia	0.00126	0.00148	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—TNF—schizophrenia	0.00126	0.00148	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	0.00119	0.0014	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PRKD1—schizophrenia	0.00119	0.00139	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—TP53—schizophrenia	0.00115	0.00135	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—DNMT1—schizophrenia	0.00114	0.00134	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—AKT1—schizophrenia	0.00113	0.00133	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—HSPA8—schizophrenia	0.00113	0.00132	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—TP53—schizophrenia	0.00111	0.0013	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—HSPA1A—schizophrenia	0.00103	0.0012	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GAPDH—schizophrenia	0.00099	0.00116	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CLOCK—schizophrenia	0.000981	0.00115	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—APOE—schizophrenia	0.000979	0.00115	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—schizophrenia	0.000975	0.00114	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	0.000968	0.00113	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—TPH2—schizophrenia	0.000956	0.00112	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CACNB2—schizophrenia	0.000956	0.00112	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—DPYD—schizophrenia	0.000941	0.0011	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	0.000938	0.0011	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CACNA1C—schizophrenia	0.000875	0.00103	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PIK3C2A—schizophrenia	0.000853	0.001	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYP2D6—schizophrenia	0.000765	0.000897	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SNAP25—schizophrenia	0.000765	0.000897	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—YWHAZ—schizophrenia	0.000745	0.000873	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYP1A2—schizophrenia	0.000692	0.000811	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—TH—schizophrenia	0.000682	0.000799	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—ESR1—schizophrenia	0.000622	0.00073	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—COMT—schizophrenia	0.000579	0.000679	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GSTP1—schizophrenia	0.000577	0.000676	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—MAOA—schizophrenia	0.000575	0.000675	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—EP300—schizophrenia	0.000558	0.000654	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ABCB1—schizophrenia	0.000546	0.00064	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PLA2G4A—schizophrenia	0.00053	0.000621	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GSTM1—schizophrenia	0.00053	0.000621	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—MTHFR—schizophrenia	0.000468	0.000549	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—APOE—schizophrenia	0.000436	0.000511	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—APOA1—schizophrenia	0.000431	0.000505	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—forebrain—schizophrenia	0.000427	0.108	CbGeAlD
Nandrolone phenpropionate—AR—forebrain—schizophrenia	0.000378	0.0953	CbGeAlD
Nandrolone phenpropionate—AR—telencephalon—schizophrenia	0.000348	0.0876	CbGeAlD
Nandrolone phenpropionate—CYP19A1—gonad—schizophrenia	0.000328	0.0826	CbGeAlD
Nandrolone phenpropionate—AR—gonad—schizophrenia	0.00029	0.0731	CbGeAlD
Nandrolone phenpropionate—CYP19A1—blood—schizophrenia	0.000285	0.072	CbGeAlD
Nandrolone phenpropionate—AR—blood—schizophrenia	0.000253	0.0637	CbGeAlD
Nandrolone phenpropionate—CYP19A1—Metabolism—EP300—schizophrenia	0.000249	0.000291	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—endocrine gland—schizophrenia	0.000248	0.0624	CbGeAlD
Nandrolone phenpropionate—CYP19A1—nervous system—schizophrenia	0.000232	0.0584	CbGeAlD
Nandrolone phenpropionate—AR—Gene Expression—AKT1—schizophrenia	0.000224	0.000263	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—central nervous system—schizophrenia	0.000223	0.0563	CbGeAlD
Nandrolone phenpropionate—AR—endocrine gland—schizophrenia	0.000219	0.0553	CbGeAlD
Nandrolone phenpropionate—AR—nervous system—schizophrenia	0.000205	0.0517	CbGeAlD
Nandrolone phenpropionate—AR—central nervous system—schizophrenia	0.000198	0.0498	CbGeAlD
Nandrolone phenpropionate—CYP19A1—brain—schizophrenia	0.000177	0.0447	CbGeAlD
Nandrolone phenpropionate—AR—brain—schizophrenia	0.000157	0.0395	CbGeAlD
Nandrolone phenpropionate—CYP19A1—Metabolism—AKT1—schizophrenia	0.00015	0.000176	CbGpPWpGaD
